| Year |
Citation |
Score |
| 2019 |
Meinert C. The trials and tribulations of the University Group Diabetes Program 1: the trial and the controversies. Journal of the Royal Society of Medicine. 112: 476-482. PMID 31710827 DOI: 10.1177/0141076819884869 |
0.328 |
|
| 2018 |
Ervin AM, Taylor HA, Ehrhardt S, Meinert CL. Why Public Comments Matter: The Case of the National Institutes of Health Policy on Single Institutional Review Board Review of Multicenter Studies. Academic Medicine : Journal of the Association of American Medical Colleges. PMID 29517531 DOI: 10.1097/Acm.0000000000002206 |
0.567 |
|
| 2015 |
Ehrhardt S, Appel LJ, Meinert CL. Trends in National Institutes of Health Funding for Clinical Trials Registered in ClinicalTrials.gov. Jama. 314: 2566-7. PMID 26670975 DOI: 10.1001/Jama.2015.12206 |
0.305 |
|
| 2015 |
Ervin AM, Taylor HA, Meinert CL, Ehrhardt S. RESEARCH ETHICS. Evidence gaps and ethical review of multicenter studies. Science (New York, N.Y.). 350: 632-3. PMID 26542556 DOI: 10.1126/Science.Aac4872 |
0.548 |
|
| 2014 |
Drye LT, Casper AS, Sternberg AL, Holbrook JT, Jenkins G, Meinert CL. The transitioning from trials to extended follow-up studies. Clinical Trials (London, England). 11: 635-47. PMID 25115882 DOI: 10.1177/1740774514547396 |
0.56 |
|
| 2014 |
Drye LT, Casper AS, Sternberg AL, Holbrook JT, Jenkins G, Meinert CL. The transitioning from trials to extended follow-up studies Clinical Trials. 11: 635-647. DOI: 10.1177/1740774514547396 |
0.506 |
|
| 2012 |
Meinert CL. Clinical Trials Handbook: Design and Conduct Clinical Trials Handbook: Design and Conduct. DOI: 10.1002/9781118422878 |
0.31 |
|
| 2011 |
Drye LT, Meinert CL. Prevention trials: Design and analysis considerations Pharmaceutical Medicine. 25: 367-378. DOI: 10.2165/11595690-000000000-00000 |
0.314 |
|
| 2011 |
Meinert CL. An Insider's Guide to Clinical Trials An Insider's Guide to Clinical Trials. 1-296. DOI: 10.1093/acprof:oso/9780199742967.001.0001 |
0.323 |
|
| 2009 |
Meinert CL. Clinical Trials: Design, Conduct and Analysis Clinical Trials: Design, Conduct and Analysis. 1-494. DOI: 10.1093/acprof:oso/9780195035681.001.0001 |
0.302 |
|
| 2007 |
Breitner J, Evans D, Lyketsos C, Martin B, Meinert C. ADAPT trial data. The American Journal of Medicine. 120: e3; author reply e5;. PMID 17349430 DOI: 10.1016/J.Amjmed.2006.09.022 |
0.304 |
|
| 2007 |
Jabs DA, Van Natta ML, Holbrook JT, Kempen JH, Meinert CL, Davis MD. Longitudinal study of the ocular complications of AIDS: 1. Ocular diagnoses at enrollment. Ophthalmology. 114: 780-6. PMID 17258320 DOI: 10.1016/J.Ophtha.2006.11.008 |
0.475 |
|
| 2007 |
Jabs DA, Van Natta ML, Holbrook JT, Kempen JH, Meinert CL, Davis MD. Longitudinal study of the ocular complications of AIDS: 2. Ocular examination results at enrollment. Ophthalmology. 114: 787-93. PMID 17210182 DOI: 10.1016/J.Ophtha.2006.07.065 |
0.519 |
|
| 2007 |
Thorne JE, Holbrook JT, Jabs DA, Kempen JH, Nichols C, Meinert CL. Effect of cytomegalovirus retinitis on the risk of visual acuity loss among patients with AIDS. Ophthalmology. 114: 591-8. PMID 17123624 DOI: 10.1016/J.Ophtha.2006.08.008 |
0.5 |
|
| 2006 |
Thorne JE, Jabs DA, Kempen JH, Holbrook JT, Nichols C, Meinert CL. Causes of visual acuity loss among patients with AIDS and cytomegalovirus retinitis in the era of highly active antiretroviral therapy. Ophthalmology. 113: 1441-5. PMID 16781775 DOI: 10.1016/J.Ophtha.2006.03.022 |
0.496 |
|
| 2006 |
Thorne JE, Jabs DA, Kempen JH, Holbrook JT, Nichols C, Meinert CL. Incidence of and risk factors for visual acuity loss among patients with AIDS and cytomegalovirus retinitis in the era of highly active antiretroviral therapy. Ophthalmology. 113: 1432-40. PMID 16766032 DOI: 10.1016/J.Ophtha.2006.03.021 |
0.496 |
|
| 2004 |
Kiri A, Tonascia S, Meinert CL. Treatment effects monitoring committees and early stopping in large clinical trials. Clinical Trials (London, England). 1: 40-7. PMID 16281461 DOI: 10.1191/1740774504Cn014Oa |
0.72 |
|
| 2004 |
Miskala PH, Bressler NM, Meinert CL. Relative contributions of reduced vision and general health to NEI-VFQ scores in patients with neovascular age-related macular degeneration. Archives of Ophthalmology (Chicago, Ill. : 1960). 122: 758-66. PMID 15136325 DOI: 10.1001/Archopht.122.5.758 |
0.682 |
|
| 2004 |
Miskala PH, Bressler NM, Meinert CL. Is adjustment of National Eye Institute Visual Function Questionnaire scores for general health necessary in randomized trials? American Journal of Ophthalmology. 137: 961-3. PMID 15126176 DOI: 10.1016/J.Ajo.2003.11.018 |
0.714 |
|
| 2003 |
Gilpin AM, Holbrook JT, Jabs DA, Meinert CL. Data and safety monitoring board deliberations resulting in the early termination of the Monoclonal Antibody Cytomegalovirus Retinitis Trial. Controlled Clinical Trials. 24: 92-8. PMID 12559647 DOI: 10.1016/S0197-2456(02)00268-4 |
0.551 |
|
| 2002 |
Davidson M, Min YI, Holbrook JT, Van Natta M, Quinn TC, Murphy RL, Welch W, Jabs DA, Meinert CL. Influence of filgrastim (granulocyte colony-stimulating factor) on human immunodeficiency virus type 1 RNA in patients with cytomegalovirus retinitis. The Journal of Infectious Diseases. 186: 1013-8. PMID 12232843 DOI: 10.1086/342956 |
0.46 |
|
| 2002 |
Davidson M, Min YI, Holbrook JT, Van Natta ML, Murphy R, Jabs DA, Welch W, Meinert CL. Use of filgrastim as adjuvant therapy in patients with AIDS-related cytomegalovirus retinitis. Aids (London, England). 16: 757-65. PMID 11964532 DOI: 10.1097/00002030-200203290-00011 |
0.466 |
|
| 2001 |
Holbrook JT, Meinert CL, Van Natta ML, Davis M, Hubbard L, Jabs DA. Photographic measures of cytomegalovirus retinitis as surrogates for visual outcomes in treated patients Archives of Ophthalmology. 119: 554-563. PMID 11296021 |
0.534 |
|
| 2001 |
Holbrook JT, Meinert CL, Jabs DA. Patient notification and follow-up after suspension of treatment protocols: Experience from four clinical trials of treatments for AIDS-related CMV retinitis Controlled Clinical Trials. 22: 62-68. PMID 11165425 DOI: 10.1016/S0197-2456(00)00112-4 |
0.579 |
|
| 2000 |
Holbrook JT, Davis MD, Hubbard LD, Martin BK, Holland GN, Jabs DA, Gilpin AK, Meinert C, Reshef DS. Risk factors for advancement of cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome Archives of Ophthalmology. 118: 1196-1204. PMID 10980764 DOI: 10.1001/archopht.118.9.1196 |
0.509 |
|
| 1995 |
Kiri A, Meinert CL. 44A Treatment effects monitoring practices as viewed through the published literature Controlled Clinical Trials. 16: 58S. DOI: 10.1016/0197-2456(95)90455-E |
0.667 |
|
| 1994 |
Holbrook JT, Meinert CL, Gilpin AK. 95P On the likelihood of finding subgroup differences in clinical trials Controlled Clinical Trials. 15: 129-130. DOI: 10.1016/0197-2456(94)90223-2 |
0.523 |
|
| 1993 |
Holbrook JT, Meinert CL. A21 Principles of agreement for post NDA clinical trials Controlled Clinical Trials. 14: 407. DOI: 10.1016/0197-2456(93)90087-T |
0.525 |
|
| 1992 |
Holbrook JT, Meinert CL. Crisis management: A coordinating center's experience with the suspension of a aids treatment protocol for a clinical trial Controlled Clinical Trials. 13: 394. |
0.521 |
|
| 1991 |
Holbrook JT, Meinert CL. Advantages and disadvantages of treatment preference designs for clinical trials Controlled Clinical Trials. 12: 622. DOI: 10.1016/0197-2456(91)90082-W |
0.542 |
|
| 1990 |
Chalmers I, Adams M, Dickersin K, Hetherington J, Tarnow-Mordi W, Meinert C, Tonascia S, Chalmers TC. A Cohort Study of Summary Reports of Controlled Trials Jama: the Journal of the American Medical Association. 263: 1401-1405. PMID 2304219 DOI: 10.1001/Jama.1990.03440100117017 |
0.406 |
|
| 1989 |
Hetherington J, Dickersin K, Chalmers I, Meinert CL. Retrospective and prospective identification of unpublished controlled trials: Lessons from a survey of obstetricians and pediatricians Pediatrics. 84: 374-380. PMID 2748270 |
0.331 |
|
| 1989 |
Meinert CL. Meta-analysis: Science or religion? Controlled Clinical Trials. 10: 257-263. PMID 2605971 DOI: 10.1016/0197-2456(89)90064-0 |
0.304 |
|
| 1982 |
Meinert CL. Funding for clinical trials Controlled Clinical Trials. 3: 165-171. PMID 6759031 DOI: 10.1016/0197-2456(82)90002-2 |
0.302 |
|
| 1981 |
Meinert CL. Organization of multicenter clinical trials Controlled Clinical Trials. 1: 305-312. PMID 7261620 DOI: 10.1016/0197-2456(81)90033-7 |
0.323 |
|
| 1981 |
Meinert C, Higgins K. Identifying published reports of clinical trials Controlled Clinical Trials. 2: 70. DOI: 10.1016/0197-2456(81)90071-4 |
0.395 |
|
| 1980 |
Meinert CL. Toward more definitive clinical trials Controlled Clinical Trials. 1: 249-261. PMID 7261616 |
0.315 |
|
| 1978 |
Patz A, Fine S, Finkelstein D, Prout T, Aiello L, Bradley R, Briones JC, Myers F, Bresnick G, Venecia Gd, Stevens TS, Wallow IHL, Chandra SR, Norton E, Blankenship G, ... ... Meinert C, et al. Photocoagulation Treatment of Proliferative Diabetic Retinopathy: The Second Report of Diabetic Retinopathy Study Findings Ophthalmology. 85: 82-106. PMID 345173 DOI: 10.1016/S0161-6420(78)35693-1 |
0.334 |
|
| 1961 |
WALLACE HM, MEINERT C, DIETER R, BEARMAN JE. Cerebral palsy in Minnesota American Journal of Public Health and the Nation's Health. 51: 417-426. PMID 13782794 DOI: 10.2105/AJPH.51.3.417 |
0.547 |
|
| Show low-probability matches. |